IPOs

Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
BioPharma Dive
Thu, 03/7/24 - 11:13 am
Boundless Bio
IPOs
Bayer
Arch Venture Partners
Biotech IPOs heated up to start 2024. Will the surge last?
BioPharma Dive
Tue, 03/5/24 - 11:06 am
IPOs
biotech
Everyone's Talking About These 2 Biotech IPO Stocks
Motley Fool
Sun, 02/25/24 - 08:55 pm
biotech
IPOs
Kyverna Therapeutics
CG Oncology
Biopharma R&D Funding Has Rebounded But Clinical Trial Starts Slowed Down in 2023, Says IQVIA Institute
Managed Healthcare Executive
Thu, 02/22/24 - 11:21 pm
clinical trials
R&D
biotech
IPOs
IQVIA
4 biotechs to watch in 2024
Pharma Voice
Wed, 02/21/24 - 11:28 am
biotech
IPOs
Alto Neuroscience
Verona Pharma
Karuna Therapeutics
Madrigal Pharmaceuticals
precision medicine
COPD
Alzheimer's disease
NASH
Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut
BioSpace
Mon, 02/12/24 - 11:51 am
Metagenomi
Bayer
IPOs
Kyverna CEO Peter Maag on courting investors in a ‘volatile’ IPO market
BioPharma Dive
Mon, 02/12/24 - 11:47 am
Kyverna Therapeutics
IPOs
Peter Maag
Gene editing biotech Metagenomi pulls off nearly $94M IPO
BioPharma Dive
Sun, 02/11/24 - 03:52 pm
IPOs
Metagenomi
gene editing
Kyverna IPO adds to biotech momentum with $319M fundraise
BioPharma Dive
Thu, 02/8/24 - 11:07 am
Kyverna Therapeutics
IPOs
autoimmune diseases
Gilead-backed Kyverna Therapeutics aims for $857.3 mln valuation in upsized IPO
Reuters
Tue, 02/6/24 - 09:17 am
Kyvera Therapeutics
IPOs
Gilead Sciences
autoimmune diseases
Fractyl Breaks the Medical Device IPO Drought with New Offering
Medical Devices and Diagnostics Industry
Sun, 02/4/24 - 12:37 pm
Fractyl Health
IPOs
diabetes
obesity
Medtech
Brain drug developer Alto Neuroscience prices $129M IPO
BioPharma Dive
Fri, 02/2/24 - 11:39 am
Alto Neuroscience
IPOs
CNS
Kyverna sets IPO range, eyeing $180M haul to fund broad autoimmune CAR-T clinical trial program
Fierce Biotech
Thu, 02/1/24 - 11:19 am
Kyverna Therapeutics
IPOs
cell therapy
autoimmune disease
Fractyl sets out $99M IPO ambitions after busy week of biotechs going public
Fierce Biotech
Mon, 01/29/24 - 11:13 am
IPOs
Fractyl Health
obesity
CNS disorder biotech Alto Neuroscience sets terms for $101 million IPO
Renaissance Capital
Mon, 01/29/24 - 11:12 am
Alto Neuroscience
IPOs
biomarkers
depression schizophrenia
ArriVent takes in $175M from second biotech IPO of the year
Fierce Biotech
Fri, 01/26/24 - 11:17 am
ArriVent Biopharma
IPOs
furmonertinib
China
non-small cell lung cancer
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology
2024 Brings Surprising Early Surge of Biotech IPOs
BioSpace
Fri, 01/19/24 - 09:43 am
biotech
IPOs
CG Oncology
Alto Neuroscience
ArriVent Biopharma
Kyverna Therapeutics
Metagenomi
CG Oncology aims for $209M IPO, as more biotechs eye path to public markets
Fierce Biotech
Thu, 01/18/24 - 11:11 am
CG Oncology
IPOs
oncology
bladder cancer
For biotech dealmakers, it’s everything, everywhere all at once
Fierce Biotech
Wed, 01/17/24 - 09:40 am
M&A
IPOs
reverse merger
venture capital

Pages